I

Immunitybio, Inc.

Biotechnology Research · United States · 1,000 employees

97 Decision makers
+11 New (6 months)
1,000 Employees
$166M Revenue
2014 Founded

Organizational Chart of Immunitybio, Inc.

Roles identified within Immunitybio, Inc.'s leadership team, from public professional data, updated 25 Oct 2026.

Department

Immunitybio, Inc.'s Full Organizational Chart

Loading…

Get their contacts on Zeliq →

Job title Department People Action

Decision makers at Immunitybio, Inc. by function

General management

Finance

Tech & product

See all Immunitybio, Inc. contacts on Zeliq

Decision makers at Immunitybio, Inc.

97 identified 8 C-Level 12 VP 77 Directors +11 new (6 months)
See them on Zeliq →

Departments actively hiring 5 departments

Engineering and technical
Finance & accounting
Other
Research
Sales

These departments at Immunitybio, Inc. are actively recruiting: a strong signal to time your outreach.

Funding and news at Immunitybio, Inc.

Funding

Last round Other · $75M
Total funding $1.5B (18 rounds)
Venture Round $10M Dec 2014
Private Equity Round $75M Jun 2015
Private Equity Round $57M Jan 2016
Private Equity Round $30M Dec 2018
Post-IPO Debt $57M Jan 2022
Post-IPO Equity $11M Jul 2022
Post-IPO Debt $50M Dec 2022
Post-IPO Equity $107M Dec 2022
Post-IPO Equity $50M Feb 2023
Post-IPO Equity $40M Jul 2023
Post-IPO Equity $270M Sep 2023
Post-IPO Debt $200M Sep 2023
Post-IPO Debt $200M Jan 2024
Post-IPO Equity $10M Jan 2024
Post-IPO Equity $100M Dec 2024
Post-IPO Equity $75M Apr 2025
Post-IPO Equity $80M Aug 2025
Post-IPO Debt $75M Mar 2026

Latest news at Immunitybio, Inc.

  1. Appointment

    New Talent Sourcing Partner appointed — Human resources

  2. Appointment

    New Director, Trade & Distribution appointed — Sales

  3. Appointment

    New Area Business Director appointed — General management

  4. Appointment

    New Director, Regulatory Affairs Cmc appointed — Legal

Get these new hires' email and phone →

Team Structure headcount by department

Hiring Research
106
Operations
67
Hiring Technical
67
Medical
55
Hiring Finance
39
Hiring Other
36
General Management
30
Project Management
26

How to prospect Immunitybio, Inc.'s departments

Research

The company's largest department (106 people), currently in an active hiring phase. Long cycles and rigorous methods: respect their pace and bring evidence, not hype.

Technical

A team of 67 people, currently hiring. Skip the marketing speak: these decision makers expect precise use cases, documentation and a quick proof of value.

Operations

With 67 people, this is the organisation's second pillar. Pitch measurable time savings and error reduction: the metrics this function is judged on.

Finance

This 39-person department is actively recruiting. Build your pitch around ROI, payback period and risk reduction: the language this department speaks.

Other

Hiring is underway in this team of 36 people. Hard to read from the outside: use a first exchange to map who does what before pushing an offer.

Sales

A team of 24 people, currently hiring. Sales leaders respect good selling: a sharp, well-researched approach is your best credential.

Try the Zeliq email finder demo →

FAQ Immunitybio, Inc.

Who runs Immunitybio, Inc.?

The highest-ranking leadership role identified at Immunitybio, Inc. is “CTO”, based on public data updated 25 Oct 2026.

How many decision makers does Immunitybio, Inc. have?

97 decision makers identified, including 8 at executive level.

How do I contact a decision maker at Immunitybio, Inc.?

Verified emails and phone numbers are available in Zeliq, with free credits at sign-up.

Which departments are hiring at Immunitybio, Inc.?

Engineering and technical, Finance & accounting and Other, based on published job offers as of 25 Oct 2026.

Companies similar to Immunitybio, Inc.

More companies to explore

Biotechnology Research · United States

All Biotechnology Research companies in United States →

About Immunitybio, Inc.

Immunitybio, Inc. is a Biotechnology Research company, operating from United States. Founded in 2014, the company counts about 1,000 employees. Within the wider Professional Services sector, Immunitybio, Inc. focuses on the Biotechnology Research segment. Immunitybio, Inc. sells primarily to other businesses (B2B) rather than to end consumers. Immunitybio, Inc. has raised funding across 18 rounds totalling $1.5B. The company generates approximately $166M in annual revenue. The data below (industry, headcount, location and business signals) helps sales teams qualify Immunitybio, Inc. and pinpoint the right decision makers from the first touchpoint.

Activity & Market

The company evolves in the Biotechnology Research segment of the Professional Services sector. As a B2B company, Immunitybio, Inc. primarily serves business clients and professional organisations. In terms of structure, it is registered as “Public company”.